Device / Technology News

RSS

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Athena™ programmer, a deep brain stimulation (DBS) therapy management system. This next-generation platform offers clinicians a powerful yet easy-to-use interface that enables them to set or adjust therapeutic parameters to optimize patient results.

20 Sep 2010

Walmart, CVS to sell NEW Handheld Power Pill Grinder for dysphagia patients

Variant Products Ltd. announced today that walmart.com and cvs.com will soon be selling its NEW Handheld Power Pill Grinder. It is significant because sales velocities are being closely monitored by both retailers for store consideration. Validating the market, Walmart and CVS currently dedicate resources to educate and address dysphagia concerns (difficulty swallowing). People who struggle with this issue often crush or grind their meds/supplements and the Power Pill Grinder offers a unique alternative to traditional manual crushers.

20 Sep 2010

Clerity achieves ISO 9001:2008 Quality Management Certification

Clerity, a full-service provider of mainframe migration, modernization, and optimization solutions, today announced that it has received ISO 9001:2008 Quality Management Certification. This independent certification validates Clerity's adherence to documented processes and procedures while delivering high-quality, global system integration solutions.

20 Sep 2010

APAF selects AB SCIEX TripleTOF 5600 System to help advance proteomics research

AB SCIEX, a global leader in life science analytical technologies, today announced that the Australian Proteome Analysis Facility has chosen the AB SCIEX TripleTOF 5600 System to help advance proteomics research by significantly expanding proteome coverage. The TripleTOF 5600 System is the life science industry's fastest and most sensitive high-resolution mass spectrometer for high-performance qualitative and quantitative analysis.

20 Sep 2010

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.

20 Sep 2010

ICF International awarded re-compete contract to provide IT, scientific support services to NCTR

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a $31.8 million re-compete contract by the U.S. Food and Drug Administration to provide information technology and scientific support services to the National Center for Toxicological Research.

20 Sep 2010

$Neovasc commences enrollment in Reducer trial for refractory angina$

Neovasc commences enrollment in Reducer trial for refractory angina

Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.

20 Sep 2010

Hatch Medical signs agreement with Majid Shano to broker super-elastic orthopedic stapling technology

Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has recently entered into an agreement with Majid Shano MB, B.CH., (Munich, Germany) to broker his patented, super-elastic orthopedic stapling technology.

20 Sep 2010

Chronix Biomedical completes Series E financing

Chronix Biomedical today announced that it has completed a Series E financing that raised $1.8 million from existing and new investors. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells. Chronix's serum DNA biomarkers are applicable to a wide range of cancers and other chronic diseases.

20 Sep 2010

Florida Hospital Fish Memorial acquires Toshiba's Xario XG ultrasound systems

Today's hospitals are under pressure to enhance patient care and streamline workflow while containing costs. To achieve this goal, Florida Hospital Fish Memorial acquired four XarioXG ultrasound systems from Toshiba America Medical Systems, Inc., to create imaging consistency across various departments.

20 Sep 2010

High-intensity exercise video game to improve health of middle aged men

Sedentary middle-aged men on Teesside in the North East of England could soon be using a high-intensity exercise video game to improve their health. For researchers at Teesside University have developed an alternative to the Nintendo Wii which doesn't allow users to cheat. Now they plan to put it to the test by getting middle-aged members of workingmen's clubs to take part in 'virtual' boxing matches with a computer-generated opponent.

20 Sep 2010

Aeris Therapeutics receives CE Mark approval for AeriSeal System to treat emphysema

Aeris Therapeutics, a company specializing in the development and commercialization of novel treatments for patients with emphysema and other advanced lung diseases, today announced that it has received CE Mark approval for its AeriSeal System.

20 Sep 2010

FluimediX receives fund for NanoCycler development

FluimediX, a point-of-care diagnostic company, announced today that it has received funding for the continued development of the NanoCycler, a diagnostic platform for the measurement of relevant genetic mutations in patients. The proceeds of this financing round will be dedicated to developing a diagnostic test for Warfarin™ metabolism.

20 Sep 2010

Scientists develop microscopic gas-filled spheres of silica to locate breast cancers

A new material could help surgeons more accurately locate breast cancers, reduce the need for second surgeries and minimize pre-surgical discomfort for patients. Microscopic gas-filled spheres of silica, a porous glass, can mark the location of early-stage tumors to show their position using ultrasound imaging in the operating room.

20 Sep 2010

Medical technology paving the way

The annual Australian technology “Academy Awards” presentation marked a significant milestone for Sydney headquartered technology company Iris Interactive taking out three awards which sets them up for the world stage. Iris Interactive started 15 years ago by a working mother, Janaki Joshi, who identified a gap in the market for enterprise software focused on product commercialisation.

19 Sep 2010

$ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study$

ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study

Medtronic, Inc. announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise for occipital nerve stimulation for treating medically refractory chronic migraines and support the need for further controlled study of the treatment. The study, called Occipital Nerve Stimulation for the Treatment of Intractable Migraine, included severely debilitated patients who had regularly experienced 15 or more headache days per month that were not responsive to currently available medical therapies.

18 Sep 2010

Lab testing is backbone of prevention: ACLA president

Sen. Tom Harkin (D-IA), chair of the Senate Health, Education, Labor and Pensions Committee and long-time advocate of prevention, will keynote a National Journal Policy Summit focused on unraveling the complexities of the cost and value of prevention in a post health reform world. The Sept. 21 event is being underwritten by the American Clinical Laboratory Association and its educational arm, Results for Life.

18 Sep 2010

PNNL, 59th Medical Wing collaborate to improve drug tests for illicit usage

A new collaboration between the Department of Energy's Pacific Northwest National Laboratory and the Air Force's 59th Medical Wing hopes to improve on drug tests for illicit drug use and abuse. Not only are the researchers looking for a better indicator of current or past use, but they'd like to be able to identify people prone to abusing drugs in the first place.

18 Sep 2010

Shrink enters final phase of commercialization program for StemDisc product line

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it is entering the final phase of its commercialization program for its first cell culturing devices for the StemDisc family of stem cell culturing products.

18 Sep 2010

FDA grants Optovue 510(k) clearance on Normative Database for RTVue OCT device

Optovue, the company that launched the first FDA cleared fourier/spectral domain OCT in the U.S., announced that it has received 510(k) clearance on its Normative Database ("NDB") for the RTVue OCT device.

18 Sep 2010

Device / Technology News

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

Walmart, CVS to sell NEW Handheld Power Pill Grinder for dysphagia patients

Clerity achieves ISO 9001:2008 Quality Management Certification

APAF selects AB SCIEX TripleTOF 5600 System to help advance proteomics research

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

ICF International awarded re-compete contract to provide IT, scientific support services to NCTR

Neovasc commences enrollment in Reducer trial for refractory angina

Hatch Medical signs agreement with Majid Shano to broker super-elastic orthopedic stapling technology

Chronix Biomedical completes Series E financing

Florida Hospital Fish Memorial acquires Toshiba's Xario XG ultrasound systems

High-intensity exercise video game to improve health of middle aged men

Aeris Therapeutics receives CE Mark approval for AeriSeal System to treat emphysema

FluimediX receives fund for NanoCycler development

Scientists develop microscopic gas-filled spheres of silica to locate breast cancers

Medical technology paving the way

ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study

Lab testing is backbone of prevention: ACLA president

PNNL, 59th Medical Wing collaborate to improve drug tests for illicit usage

Shrink enters final phase of commercialization program for StemDisc product line

FDA grants Optovue 510(k) clearance on Normative Database for RTVue OCT device

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News